drug

vamorolone

1 story · latest Sep 29, 2026

Status: FDA approved Oct 2023 · NDA215239
Brand: Agamree
Trials: 1 registered trial in coverage

Relationships

Developed by Gyre Therapeutics, Inc.

Timeline

Aquestive Therapeutics adds Rich Daly to board of directors

Sep 29PeopleAquestive Therapeutics, Inc.

Biotech intelligence from primary sources. Every story is an original summary of a public record, linked to its source. Not investment advice.

Terms Privacy hello@readthrough.news

readthrough is a product of JAMN Ventures, LLC.